FDA Proposes Changes to Biologics Regulations for License Revocation Notifications

Summary

The Food and Drug Administration (FDA) is proposing to update its biologics regulations to align with current practices for notifying the public about license revocation, as part of a companion document to a direct final rule published in the Federal Register.